John Neis

CLRB

DIRECTOR · CELLECTAR BIOSCIENCES, INC. · CIK 0001167426

FILING MIX · LIFETIME50%/50%

BUYS

SELLS

TOTAL VALUE

$67.9K

COMPANIES

ACTIVE SINCE

Jun 2020

HOLDINGS NOW

AVG SELL PX

$0.29

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

6 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by John Neis, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	6	+100.00%	-12.48%	-0.87%	-11.61%	-11.93%	—
14d	6	+100.00%	-19.54%	+0.84%	-20.38%	-20.50%	—
30d	6	+83.33%	-21.68%	+4.77%	-26.45%	-33.25%	—
60d	6	+100.00%	-29.28%	+4.90%	-34.18%	-38.77%	—
90d	6	+100.00%	-27.22%	+6.05%	-33.27%	-37.07%	—
180d	6	+100.00%	-44.63%	+12.88%	-57.51%	-60.77%	—
1y	6(1 pending)	+100.00%	-74.02%	+11.28%	-85.30%	-85.48%	—
2y	6(1 pending)	+100.00%	-92.12%	+1.87%	-93.99%	-93.92%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

CLRB · 10 shares · as of Dec 12, 2025

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

2022

2023

2024

2025

FLOW · 6 buys / 6 sellsCOVERAGE · 23 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
CLRB CELLECTAR BIOSCIENCES, INC.	SALE	198	$3.70	$732	10	Dec 12, 2025	Dec 16, 2025 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	60,000	—	—	60,000	Feb 14, 2025	Feb 18, 2025 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	60,000	—	—	60,000	Jun 14, 2024	Jun 18, 2024 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	25,000	—	—	47,887	Jun 28, 2023	Jun 28, 2023 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	7,800	—	—	7,800	Jun 24, 2022	Aug 1, 2022 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	78,000	—	—	78,000	Jun 30, 2021	Jul 2, 2021 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	SALE	23,232	$0.25	$5.9K	0	Mar 18, 2021	Mar 19, 2021 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	SALE	58,640	$0.28	$16.3K	23,232	Mar 17, 2021	Mar 19, 2021 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	SALE	100,515	$0.31	$31.1K	81,872	Mar 16, 2021	Mar 16, 2021 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	SALE	11,200	$0.27	$3.0K	182,387	Mar 15, 2021	Mar 16, 2021 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	SALE	41,155	$0.27	$11.0K	193,587	Mar 12, 2021	Mar 16, 2021 ↗	View →
CLRB CELLECTAR BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	50,000	—	—	50,000	Jun 24, 2020	Jun 25, 2020 ↗	View →

Other insiders · CLRB

Loading peer insiders…

About this filer

CIK 0001167426

ROLE

Director

PRIMARY

CLRB

COMPANIES

ACTIVE SINCE

Jun 2020

MARKETPEEL · /INSIDER/0001167426DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

John Neis

The morning brief, before the bell.